Experienced in Neonatal Ovarian Cyst

Dr. William J. Lowery

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Community Physicians Of Indiana Inc
1440 E County Line Rd, Suite 1200, 
Indianapolis, IN 
Accepting New Patients
Offers Telehealth
Experienced in Neonatal Ovarian Cyst
Community Physicians Of Indiana Inc
1440 E County Line Rd, Suite 1200, 
Indianapolis, IN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Lowery is a Gynecologic Oncologist and an Oncologist in Indianapolis, Indiana. Dr. Lowery is rated as an Experienced provider by MediFind in the treatment of Neonatal Ovarian Cyst. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Endometrial Stromal Sarcoma, and Hysterectomy. Dr. Lowery is currently accepting new patients.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in IN
Hospital Affiliations
Community Hospital North
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

COMMUNITY PHYSICIANS OF INDIANA INC
1440 E County Line Rd, Suite 1200, Indianapolis, IN 46227

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
Enrollment Status: Completed
Publish Date: November 13, 2025
Intervention Type: Other, Drug
Study Drugs: Letrozole, Paclitaxel, Pegylated liposomal doxorubicin hydrochloride, Tamoxifen citrate, Topotecan, Trametinib dimethyl sulfoxide
Study Phase: Phase 2/Phase 3
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 2
Randomized Phase II Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in HER2/Neu+ Patients With Advance/Recurrent Uterine Serous Papillary Carcinoma
Randomized Phase II Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in HER2/Neu+ Patients With Advance/Recurrent Uterine Serous Papillary Carcinoma
Enrollment Status: Completed
Publish Date: May 17, 2023
Intervention Type: Drug
Study Drugs: Carboplatin/Paclitaxel, Trastuzumab
Study Phase: Phase 2
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Other, Drug, Biological
Study Drugs: Dactinomycin, Leucovorin Calcium, Methotrexate
Study Phase: Phase 3
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

27 Total Publications

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 27, 2022
Similar Doctors
Advanced in Neonatal Ovarian Cyst
Dr. Jonathan B. Lupton
Obstetrics and Gynecology
Advanced in Neonatal Ovarian Cyst
Dr. Jonathan B. Lupton
Obstetrics and Gynecology

Seven Hills Ob-Gyn Associates LLC

8051 S Emerson Ave, 400 Obgyn Of Indiana South, 
Indianapolis, IN 
 (3.2 miles away)
317-865-3600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathan Lupton is an Obstetrics and Gynecologist in Indianapolis, Indiana. Dr. Lupton is rated as an Advanced provider by MediFind in the treatment of Neonatal Ovarian Cyst. His top areas of expertise are Menorrhagia, Neonatal Ovarian Cyst, Ovarian Cysts, Endometrial Polyps, and Intrauterine Device Insertion. Dr. Lupton is currently accepting new patients.

Advanced in Neonatal Ovarian Cyst
Dr. James R. Dunlop
Gynecologic Oncology | Obstetrics and Gynecology
Advanced in Neonatal Ovarian Cyst
Dr. James R. Dunlop
Gynecologic Oncology | Obstetrics and Gynecology
8051 S Emerson Ave Ste 400, 
Indianapolis, IN 
 (4.2 miles away)
317-865-3600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Dunlop is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Indianapolis, Indiana. Dr. Dunlop is rated as an Advanced provider by MediFind in the treatment of Neonatal Ovarian Cyst. His top areas of expertise are Ovarian Cysts, Neonatal Ovarian Cyst, Menorrhagia, Polycystic Ovary Syndrome, and Intrauterine Device Insertion. Dr. Dunlop is currently accepting new patients.

Advanced in Neonatal Ovarian Cyst
Dr. Vicky E. Sherman
Obstetrics and Gynecology
Advanced in Neonatal Ovarian Cyst
Dr. Vicky E. Sherman
Obstetrics and Gynecology

Seven Hills Ob-Gyn Associates LLC

8360 S Emerson Ave, Suite 100, 
Indianapolis, IN 
 (2.9 miles away)
317-859-2535
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vicky Sherman is an Obstetrics and Gynecologist in Indianapolis, Indiana. Dr. Sherman is rated as an Advanced provider by MediFind in the treatment of Neonatal Ovarian Cyst. Her top areas of expertise are Ovarian Cysts, Nabothian Cyst, Neonatal Ovarian Cyst, Angiomyoma, and Intrauterine Device Insertion. Dr. Sherman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lowery's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 16 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile